Evidence map›Paper›PMID 38634047›Full record

ArticleFrontiers in oncology2024

Case report: Characteristics and nature of primary cardiac synovial sarcoma.

Tomonori Kawasaki, Tomomi Nakajima, Tomoaki Torigoe, Kojiro Onohara, Kentaro Ishii, Satoshi Kanno, Chisako Muramatsu, Rikito Tatsuno, Takahiro Jubashi, Jiro Ichikawa

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Tomonori KawasakiDepartment of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
Tomomi NakajimaDepartment of Cardiovascular Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
Tomoaki TorigoeDepartment of Orthopedic Oncology & Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
Kojiro OnoharaDepartment of Radiology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kentaro IshiiDepartment of Orthopedic Oncology & Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
Satoshi KannoDepartment of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
Chisako MuramatsuFaculty of Data Science, Shiga University, Hikone, Japan.
Rikito TatsunoDepartment of Orthopedic Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan.
Takahiro JubashiDepartment of Orthopedic Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan.
Jiro IchikawaDepartment of Orthopedic Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan.
Saitama Medical University · JPUniversity of Yamanashi · JPSaitama International Medical Center · JPShiga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary malignant cardiac tumors rarely occur, and cardiac synovial sarcoma (SS) is especially rare among such tumors. Herein, we present the case of a 35-year-old female with primary cardiac SS treated with surgery, chemotherapy, and radiotherapy. She presented with chest symptoms and underwent imaging examinations. A cardiac tumor was suspected, and an open biopsy was performed. The pathological findings suggested cardiac SS. Next, we performed a resection, and the tumors persisted at a macroscopic level. Immunohistochemistry was negative for SS18-SSX and positive for the SSX C-terminus and cytokeratin CAM5.2, a reduction of SMARCB1/INI1 was observed, and fluorescence

Indexed as

cardiac tumorchemotherapydiagnosisfluorescence in situ hybridizationimmunohistochemistryradiotherapyynovial sarcoma

Identifiers

PMID38634047
PMCPMC11022687
OpenAlexW4393910716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.